Get access to the best calls on Wall Street with StreetInsider.com’s Ratings Insider Elite. Get your Free Trial here.
Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced a major corporate restructuring with the objective of prioritizing and segregating its research and development efforts on a focused set of products in inflammatory disease and dermatology and strengthening its financial position.
In line with this prioritization, the Company’s Board of Directors has authorized Dr. Daniel Teper to lead the Company’s oncology business within the Company’s Cytovia, Inc. subsidiary and to pursue a possible spin-off of Cytovia into a separate, stand-alone company independent from Immune. Cytovia will focus on the development and comm…
Read the full article at: https://www.streetinsider.com/Corporate News/Immune Pharma (IMNP) Announces Corporate Restructuring, CEO to Resign/12804462.html